Jianzhong Ye

State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Health Outcomes Studied

• Improved Gut Microbiome
• Improved Gut Microbiota Composition
• Improved Gut Microbiota Diversity
• Increased Energy Levels
• Increased Interleukin-10 Levels
• Increased SCFA Levels
• Reduced Body Weight

Papers (7)

• 2021
  Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats.10.1039/d0fo02530e
• 2021
  Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI0110.1007/s00253-021-11099-z
• 2020
  Pediococcus pentosaceus LI05 alleviates DSS‐induced colitis by modulating immunological profiles, the gut microbiota and short‐chain fatty acid levels in a mouse model10.1111/1751-7915.13583
• 2020
  Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice10.1007/s00253-020-10621-z
• 2019
  Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats10.1007/s00253-019-10211-8
• 2018
  Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats10.1007/s00253-018-9454-y
• 2017
  Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats10.1038/s41598-017-07091-1